Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVANESCE-II: FemPulse System for Overactive Bladder
NCT07195656Recruiting
- Sponsor
- FemPulse
- Start
- Sep 2025
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Trial in overactive bladder (OAB) (2 arms), sponsored by FemPulse. Primary endpoint: Mean Change in Voids per Day at 6 months. Started Sep 2025; status: recruiting.
02
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT07195656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07195656.